Anatolia Tani ve Biyoteknoloji Ãrünleri Ar-Ge Sanayi Ticaret A.S. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TRY 268.82 million compared to TRY 410.11 million a year ago. Net income was TRY 330.39 million compared to TRY 433.33 million a year ago.
Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret
Equities
ANGEN
TREANGN00028
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.28 TRY | -1.12% | -5.41% | +6.67% |
1st Jan change | Capi. | |
---|---|---|
+6.67% | 90.18M | |
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |
- Stock Market
- Equities
- ANGEN Stock
- News Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret
- Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. Reports Earnings Results for the Full Year Ended December 31, 2022